Navigation Links
Kewaunee Scientific Corporation Increases Quarterly Dividend
Date:5/29/2008

STATESVILLE, N.C., May 29 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) announced today that its Board of Directors increased the Company's quarterly cash dividend to eight cents per outstanding share, up from seven cents per share declared in the previous quarter, payable on June 23, 2008 to stockholders of record at the close of business on June 9, 2008.

Kewaunee Scientific Corporation is a recognized leader in the design, manufacture, and installation of scientific and technical furniture. The Company's corporate headquarters and manufacturing facilities are located in Statesville, North Carolina. The Company also has subsidiaries in Singapore and Bangalore, India that serve the Asian markets. Kewaunee Scientific's website is located at http://www.kewaunee.com .

Contact: D. Michael Parker

704/871-3290


'/>"/>
SOURCE Kewaunee Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related medicine news :

1. Texas Jury Awards $250 Million Patent Infringement Verdict Against Boston Scientific in Balloon Catheter Lawsuit
2. NIDCR strategies for future scientific success
3. Pharsight Invited to Present on Modeling and Simulation at ARCS Australia Scientific Congress
4. Novadaqs SPY System was Topic of Best Poster in Scientific Session at AUA
5. ASINEX and CDD Team up for Open Access Data for the Scientific Community
6. Dr. Michael Brownlee receives JDRF Rumbough Award for Scientific Excellence
7. 2008 American Academy of Pediatric Dentistry Annual Session Highlights Emerging Scientific Advancements
8. SCAI announces 2009 annual scientific sessions in Las Vegas
9. CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting
10. Milestone Scientific to Exhibit at the DPRWorld(TM) 08 in Las Vegas, Nevada
11. Milestone Scientific to Announce First Quarter 2008 Results on Thursday, May 15, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...Va., Nov. 21 New resear...her a smokeless, spitless tobacco product aimed at...have found that RJ Reynolds, Camel Snus - touted a... contains surprisingly high levels of nicotine. ,...ost other snuff products," said Bruce Adkins of th...
(Date:11/21/2008)...ders Intend To Vigorously Protect Investment And R...v. 21 Dr. Stephen Joffe...dment to their Schedule 13D with the U.S. Securiti...filed a 13D disclosing ownership of 11.4% of LCA-V...asikPlus fixed-site laser vision correction center...
(Date:11/21/2008)... 21 The general membership of the ...three new individuals at their Annual,Awards Dinn...l in New York. A,Lifetime Achievement Award will ...e Medical Advertising Hall of Fame are: , Ronal...an account position,at Sudler & Hennessey. In...
(Date:11/21/2008)..., Nov. 21 Barr Pharmaceu...ts shareholders overwhelmingly approved the propos...of Barr by Teva Pharmaceuticals Industries Ltd. (N...rated the overwhelming support of the transaction ...arr,s Chairman and CEO. "We are pleased with the p...
Breaking Medicine News(10 mins):Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4
...es virus that causes infectious mononucleosis, Eps...ntribute to the development of Hodgkin's disease. ... between EBV and Hodgkin's survival, according to ... A. Clarke from Northern California Cancer Center ...
...C and the British Scientific journal Human Reprodu... scientists has successfully altered the genetic m...he scientists who developed the technique in the U... children had been born with altered genes.However...
...h scientists have started exploring possibilities ...nt need indole acetic acid to bend shoots toward s... the Cancer Research Campaign (CRC), a leading sci...ments to IAA to kill cancer cells. Indole ace...
...s of two new studies suggest that low-dose estroge...t for women experiencing menopausal hot flushes an...ity says low-dose estrogen therapy is as effective...pausal symptoms. Low-doses are actually are more e...
Other Medicine News:
(Date:11/20/2008)...Nov. 20 New Jersey American Water ... for its customers in the following municipalities..., Middlesex County , , , Dunelle...ataway , South Plainfield , , , ...rook , Bridgewater , Green Brook , ...
(Date:11/20/2008)... Nov. 20 Bionovo, Inc.,...nt results from the Phase 1B,clinical trial of th...east,cancer, BZL101, at the Society for Integrati...tlanta, Georgia. The Company,s oral presentation ...e presented as a part of the Best of the,SIO Sess...
(Date:11/20/2008)... November 20 The Scandinavian-base...nounced results of studies on its,lead antimicrob...ngton, DC,the studies showed that the novel lyti... effect, significantly better towards killing Stap... marketed gold standard drugs. In,addition to thi...
(Date:11/19/2008)... Nov. 19 Biotech scientists increa...ology research to better understand the effects of...ms, reports Genetic Engineering & Biotechnolo...n figuring out a new compound,s mechanism of actio...y technique, according to the November 15 issue of...
Breaking Medicine Technology:New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Take Care Health Systems Names Butler Shine Stern 26 Partners as First Marketing Agency of Record 14322 1Take Care Health Systems Names Butler Shine Stern 26 Partners as First Marketing Agency of Record 14322 2Take Care Health Systems Names Butler Shine Stern 26 Partners as First Marketing Agency of Record 14322 3New research provides dynamic visualization of simplest circadian clock 14321 1New research provides dynamic visualization of simplest circadian clock 14321 2All eyes and ears on the corn genome 2496 1All eyes and ears on the corn genome 2496 2All eyes and ears on the corn genome 2496 3Study in Circulation Research details how diabetes drives atherosclerosis 14319 1Study in Circulation Research details how diabetes drives atherosclerosis 14319 2Study in Circulation Research details how diabetes drives atherosclerosis 14319 3
...n Cancer Treatment,Decisions , SALT LAKE CITY, UT,...GN) (<a target="_blank" href=,"http://www.myriad.c...ented studies for a new technology that might be u...atic tumor, on Monday,April 16, 2007 at the annua...esearch (AACR) in Los Angeles, California. This wo...
..., Switzerland, April 19, 2007 /PRNewswire/ -- Debi...opharmaceutical,development specialist in oncology...nal results of a previous phase Ib, 15 day study,w...CV (hepatitis C,virus) co-infected patients. The d...he European Association for the Study of the,Liver...
Other Medicine Technology:Myriad Genetics Presents Tumor Origin Technology at AACR 2Myriad Genetics Presents Tumor Origin Technology at AACR 3Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment,of HCV 2Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment,of HCV 3Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment,of HCV 4
DrDrugs®: Drug Guide for Physicians - now with over 760 Integrated Calculators - combines the most comprehensive, up-to-date and practical drug resource with built in drug dosing calculation too
Clinician's Pocket Drug Reference 2005 includes key elements of commonly used medications that are essential information for both the student and practicing physician.
The pharmaceutical subset of the authoritative 2005 edition of Title 21 of the Code of Federal Regulations (CFR) with proposals and final rules published in the Federal Register. Content is updated r
The Quality Module QS I evaluates and classifies the quality and quantity of centrifuged serum samples. The System analyses the tube, volume and cap and recognizes if a sample contains hemolytic, lip
Medicine Products: